
4D Molecular Therapeutics (FDMT) Latest News & Updates
Explore latest FDMT News and Updates
Stay updated on FDMT with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in FDMT
Order type
Buy in
Order amount
Est. shares
0 shares
4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
GlobeNewsWire •

GlobeNewsWire •

GlobeNewsWire •


GlobeNewsWire •

Zacks Investment Research •

Seeking Alpha •

Seeking Alpha •

GlobeNewsWire •

Seeking Alpha •


Seeking Alpha •

Zacks Investment Research •

GlobeNewsWire •

Zacks Investment Research •

GlobeNewsWire •

GlobeNewsWire •

Seeking Alpha •

Seeking Alpha •


Seeking Alpha •



GlobeNewsWire •

